Clinical Trials Logo

Clinical Trial Summary

Literature on the topic of athlete gut microbiota is scarce, and even more on the topic of its modulation. To address these issues a prospective cohort study was conceived. The cohort included young, male generally healthy professional athletes. The cohort will first be exposed to a course of sauerkraut supplementation as a synbiotic. Then the cohort will be observed without any intention for gut microbiota modulation. Before and after each study phase a gut microbiota analysis will be performed for its parameters. The aim of this study is to assess whether the intervention leads to significant changes in the gut microbiota parameters in all subjects and if yes what the signal of the intervention was, meaning whether the changes were consistent among all subjects regarding the analyzed parameter and its direction of effect. The results will be compared with data from earlier research on gut microbiota modulation in professional athletes with soluble fiber as prebiotics and a placebo. The study will provide valuable data on the athlete gut microbiota and its potential modulation.


Clinical Trial Description

Material, participants, methodology and research plan The subject of the research will be interventions with sauerkraut to modulate the intestinal microbiota as a synbiotic as a substance whose effect has been established in previous scientific research on humans, and which, due to the low incidence of side effects, have been assessed as generally safe. The intervention will refer to the use of sauerkraut. During 10 days, the subjects will consume approximately 250 g of sauerkraut (Brassica oleracea v. capitata) daily. The research material is a donation from the company Eko Bio Zrnje, Vrbovec, Croatia. It's grated pickle cabbage produced by fermentation in a saline solution (NaCl) in which the fermentation was stopped by pasteurization and was packed in glass 500g jars. The nutritional and microbiological composition was tested by the laboratories of the Faculty of Food and Biotechnology, as well as by the cultural laboratory approach confirmed the presence of bacteria that produce lactic acid (4.82·103 (±2.31) colony forming unit/mL) with potential probiotic due to which this product can be considered a synbiotic. Additionally, sauerkraut was analyzed using 16s ribosomal ribonucleic acid natural guide star next-generation sequencing nonconvulsive generalized status epilepticus normal goat serum methods on the presence of genetic material of bacteria within it. With regard to pasteurization, sauerkraut will not be necessary transport and store according to the cold chain principle. The results of the intervention regarding the modulation of the intestinal microbiota will be compared with those from the previous research in which the subject is research was the modulation of intestinal microbiota by soluble fiber NUTRIOSE in professional athletes. NUTRIOSE are resistant maltodextrin, i.e. non-viscous soluble fibers obtained from wheat and corn (Roquette Freres, Lestrem, France) with proven prebiotic action. respondents For the purposes of the research, a cohort will be formed with a minimum of nine respondents - professional athletes. The sample of respondents was determined technical, logistical and financial conditions of the research, and is based on the fact that the comparison with cohorts of 9 subjects from a previous study (NCT05726435) who were exposed to the intervention with prebiotics and controlled by placebo with the aim modulation of the intestinal microbiota of professional athletes. The recruitment of respondents will be carried out in cooperation with research partners (HOO) and from the researcher's social environment using an online questionnaire. Methodology Work methods: dietetic methods, anthropometric methods and collection and analysis of venous blood and stool samples. The sample of variables consists of: a sample of feces for sequencing the intestinal microbiota, a sample of venous blood for laboratory processing, measures for the assessment of morphological characteristics (body height, body mass, percentage of fat tissue and muscle tissue calculated using the analyzer for body composition - TANITA bioimpedance). Dietetic methods will be used to control the intake of all nutrients before and during the intervention as well as during the follow-up phase. From the method will be a food diary (seven-day and ten-day). All collected dietary data will be processed through Capnutr atlas of foodstuffs and ready meals from the Balkan region (Glibetić et al., 2018). Research plan The research was designed as a prospective cohort study. The research will be conducted in compliance with the regulations of the Declaration of Helsinki and in accordance with the approval of the Ethics Committee of the Faculty of Medicine of the University of Zagreb dated 27.3.2023. Research will to be carried out in two phases: in the first phase, the subjects will be supplemented with sauerkraut for ten days, and in the second phase of one month will be monitored for intestinal microbiota without attempting to modulate the intestinal microbiota ("wash-out"). In cooperation with HOO and academic and business partners, professional athletes will be invited to fill out the virtual form "Athletes and intestinal microbiome", that is, a questionnaire about athletes' knowledge about the intestinal microbiome. Data processing will identify potential candidates for Research. Candidates will be contacted by phone, informed about the research and evaluated in a short conversation regarding the criteria on and off. Candidates who meet the criteria will be included in the cohort. After the establishment of the cohort, logistical arrangements will be made and study plan plan. The study will be divided into three phases: before, during and after the intervention. First, the subjects will be informed about the study plan (time, number of visits, logistics) for which informed consent was obtained. In the pre-intervention phase, there will be a meeting in which more once explain the plan and course of the study, define the deadlines and distribute the equipment for taking the sample and send the provided forms (Excel, Microsoft Office, USA). In the continuation of the first phase, the respondents will record daily food intake, duration and intensity of physical activity as well as sleep time. Likewise, questionnaires on the question of the quality of diet (DQQ), a questionnaire on knowledge about nutrition and chronotype questionnaire. The day before the start of the intervention, the subjects will provide a stool and blood sample, and then fill out the acceptable daily intake. During the intervention respondents are in continuous communication with the team of researchers. In a specially provided form, they record adherence to the intervention (data i time of intake of cabbage, for example) and possible side effects (changes in the stool, flatulence, wind) as well as the type of stool according to the Bristol scale. During intervention subjects continue to keep a diet, exercise and sleep diary. After the intervention, they give a blood sample again and a sample of the first one chairs after the intervention, according to the same principle as before the intervention. Likewise, the respondents will fill out the ADI again. In the second phase research subjects remain in communication with the researchers, and two months after the last stool sample is taken again a stool sample from the subject and the analysis of the intestinal microbiota is performed again. During data processing, the results of this research will be compared with the results of the previous research, which is different from this one research used prebiotics and not synbiotic in the intervention. Previous research registered in the ClinicalTrials.gov registry under no NCT05726435 was designed as a randomized placebo-controlled intervention study. The respondents, professional athletes, were during the 4 weeks, one group received either prebiotics, NUTRIOSE fibers, or a placebo in the amount of 20g divided into two doses of 10g each. Analysis intestinal microbiota were performed on several occasions during the described intervention. The results of this research will be compared specifically with the results of the intestinal microbiota analysis at two time points: after 2 weeks of the intervention and 8 weeks from the start of the intervention, when the subjects were 4 weeks without prebiotics or placebo after the intervention itself. Data processing methods: Differences between categorical variables will be tested using the chi-square test. Differences between non-categorical variables will be examined, depending on distribution and number of groups, paired t-test as well as Kruskal-Wallis and Mann-Whitney U test and then Bonferoni test for post hoc analysis. In order to examine possible correlations, the calculation of Pearson correlation coefficients between parameters of nutritional status will be used, body composition and diet. The questionnaires will be validated by calculating the Cronbach alpha coefficient for each of their items and through an exploratory one factor analysis, and internal consistency will be determined by calculating Pearson's correlation coefficients between individual items questionnaire. The relative shares of individual taxonomic categories will be used to calculate the Shannon-Wiener diversity index in order to compared the diversity between the group of samples before and after the intervention. Cluster analysis will be performed using the BioNumerics program (Applied Maths, Belgium) based on Haemophilus haemolyticus restriction endonuclease I and MSPi T-restriction fragment length polymorphism patterns. P values below 0.05 will be considered statistically significant. For statistical data processing will be carried out using the SPSS 19.0 program (IBM, Chicago, USA). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06087146
Study type Interventional
Source The Gut Microbiome Center (Centar za crijevni mikrobiom)
Contact
Status Completed
Phase N/A
Start date October 31, 2023
Completion date November 29, 2023

See also
  Status Clinical Trial Phase
Active, not recruiting NCT05371704 - The Effect of Micronutrient Supplementation on Gut Microbiome Composition and Function N/A
Recruiting NCT05961189 - Influence of Short-Term Antibiotic Therapy on Exercise Early Phase 1
Not yet recruiting NCT06126094 - Benefits of Alcoholic Hangover Medicine N/A
Not yet recruiting NCT05364736 - Effect of Prebiotics on Blood Pressure Management N/A
Completed NCT03949543 - The Timing of Main Meal Consumption Effect on Gut Microbiota and Host N/A
Recruiting NCT05636670 - Assessment of Cognitive Function and Gut Microbiota Analysis in Real World Patients With Lupus Cerebrovascular Disease
Completed NCT02998177 - Characterization of Rebound Pain Following Peripheral Nerve Block and Its Association With Gut Microbiome Diversity N/A
Recruiting NCT05657730 - Study the Effect of Water Kefir Consumption on the Gut Microbiome in Healthy Adults N/A
Active, not recruiting NCT03978104 - Impact of Okara and Bio-okara Food Product on Gut and Glycaemic Health in Middle-aged and Older Adults in Singapore N/A
Terminated NCT04059666 - Gastrointestinal Tract Microbiome in Healthy Term Infants Receiving Mother'S-own Breast Milk or Cow's Milk-based Infant Formulas N/A
Completed NCT04088474 - Effects of Vigiis 101-LAB on a Healthy Populations' Gut Microflora N/A
Not yet recruiting NCT06332898 - The Effects of a Nutritional Supplement on Nutrient Status and Quality of Life N/A
Completed NCT04046432 - Effects of Vigiis 101-LAB on a Healthy Populations' Gut Microflora, Peristalsis, Immunity, and Anti-oxidative Capacity N/A
Completed NCT05729269 - Characterization of Gut Microbiota in Chronic Liver Disease With Decreased Muscle Mass
Recruiting NCT05692024 - COffee and Metabolites Modulating the Gut MicrobiomE in Colorectal caNCER Phase 1/Phase 2
Not yet recruiting NCT06207136 - Microbiome and Diet in Parkinson's Disease N/A
Recruiting NCT03812445 - Cognition and Gut Microbiome Associated Study of Shanghai People With Acute Ischemic Stroke N/A
Not yet recruiting NCT04947930 - Fecal Metagenomics and Metabolomics Analyses to Identify Potential Screening Biomarkers for Colorectal Polyps and Cancer in Chinese Population
Completed NCT02867605 - Human Pilot Study - HA35 (Hyaluronan Molecular Weight 35) Dietary Supplement for Promoting Intestinal Health N/A
Recruiting NCT04031469 - A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease